Physician profile
David Alan Rush
NPI 1396039434
$15,176.21
in general payments reported to CMS, 2019-2025
14 companies · $868 in 2025
The $868 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,032 · 2020: $2,094 · 2021: $6,982 · 2022: $3,074 · 2023: $102 · 2024: $24.35 · 2025: $868.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $506 · Travel and Lodging: $488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $506.08 |
| Travel and Lodging | $488.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $8,899.76 | 2019-2022 | |
| Arthrex, INC. | $2,531.40 | 2020-2025 | |
| Anika Therapeutics, INC. | $1,506.94 | 2022 | |
| Zimmer Biomet Holdings, INC. | $1,216.71 | 2021-2022 | |
| Stryker Corporation | $333.43 | 2022-2025 | Aequalis Perform, Blueprint Patient Specific Instrumentation |
| Linkbio Corp | $160.54 | 2021 | |
| P Bar Medical LLC | $140.82 | 2025 | |
| Axogen | $103.43 | 2020 | |
| Skeletal Dynamics INC | $84.23 | 2019 | |
| Depuy Synthes Sales INC. | $51.13 | 2025 | Va-Lcp, Na |
| Innovation Technologies INC | $49.20 | 2023-2024 | Irrisept |
| Integra Lifesciences Corporation | $38.76 | 2019-2023 | Tenoglide |
| Acumed LLC | $32.00 | 2021 | |
| Dynasplint Systems INC. | $27.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Rush listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.